Registry Study of Patients Aged 18 and Older with Pulmonary Arterial Hypertension at Hospital Italiano de Buenos Aires

What this Trial Is About

Researchers are creating a registry of patients with Pulmonary Hypertension who receive medical care at the Hospital Italiano of Buenos Aires. The study includes both new cases of pulmonary hypertension type I and existing patients diagnosed before the registry began, following updated diagnostic guidelines. This registry aims to gather important data on this condition to better understand its occurrence and outcomes. This is an observational study without treatment interventions. It enrolls patients diagnosed with Pulmonary Arterial Hypertension PAH WHO group 1 based on specific hemodynamic criteria from the 2022 ESCERS guidelines. Patients are included prospectively or as prevalent cases within the hospitals health maintenance organization. Participants will be monitored to collect data on the prevalence and incidence of pulmonary hypertension over one year. Researchers will also track mortality rates within that timeframe. The study involves reviewing medical records and clinical information. Participation continues as long as the patient remains in care, with the registry ongoing since 2017 and expected to continue through 2031.

Pulmonary Hypertension Institutional Registry at Hospital Italiano de Buenos Aires